A new study shows that blood collected on a sanitary pad can be used for cervical cancer screening, opening the door to new diagnostics ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

About 70 per cent of cases are prevented through cervical screening, according to cancer research, and the HPV vaccine is ...

Despite these totals, the long-term trend in cancer mortality reflects significant progress. As of 2023, the age-adjusted cancer death rate had dropped by 34% from its peak in 1991, averting an ...

The webcast from the conference will also be available on UroGen’s corporate website, under Events & Presentations. A replay will be available for approximately 90 days.

On World Cancer Day, we look at the companies accelerating breakthroughs across the cancer pipeline, from screening to recovery.

Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study from China published by The ...

Radiation and microgravity are two of the greatest hazards to astronauts’ reproductive health. “Space radiation can damage ...

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the ...

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from ...

When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...